FDA issued a Warning Letter to Dexcowin Co. Ltd. on 2/20/2018 as a result of this inspection.
483 Dexcowin Aug 2017$119 - Not in Stock
FDA investigators audited the Dexcowin - Gansan-dong, Geumcheon-gu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 31 Aug 2017.
- Category: Medical Devices & Rad Health
- Inspection end: 31 Aug 2017
- Location: Gansan-dong, Geumcheon-gu, Korea (the Republic of)
- FEI: 3007065358
Pre-Order Not Available